[EN] SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS<br/>[FR] DÉRIVÉS SUBSTITUÉS D'ARYLES ET D'HÉTÉROARYLES FUSIONNÉS AU TITRE D'INHIBITEURS DE PI3K
申请人:INCYTE CORP
公开号:WO2011075630A1
公开(公告)日:2011-06-23
The present invention provides fused aryl and heteroaryl derivatives of Formula I that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS
申请人:Li Yun-Long
公开号:US20110183985A1
公开(公告)日:2011-07-28
The present invention provides fused aryl and heteroaryl derivatives of Formula I:
wherein X, V, Y, U, W, Z, R
1
, R
2
, Cy, and Ar are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
The title radical rotamers were generated by thermolyses of the corresponding t-butyl peroxycarboxylates or photolyses of the corresponding 2(1H)-thioxo-1-pyridyl carboxylates. Products from the t-butyl peroxyesters were t-butoxy compounds, dimers, and colligation products with a benzyl radical, when the reactions were carried out in toluene. In carbon tetrachloride, chlorine-abstraction products and